Scarica l'app Stockscreener
0.7502
5.50%
0.0391
Pre-mercato:
.81
0.0598
+7.97%
Precedente Chiudi:
$0.7111
Aprire:
$0.7215
Volume 24 ore:
40,458
Relative Volume:
0.59
Capitalizzazione di mercato:
$9.60M
Reddito:
$2.48M
Utile/perdita netta:
$-12.16M
Rapporto P/E:
-0.7341
EPS:
-1.0219
Flusso di cassa netto:
$-10.35M
1 W Prestazione:
+22.98%
1M Prestazione:
+27.15%
6M Prestazione:
-73.49%
1 anno Prestazione:
-73.21%
Intervallo 1D:
$0.65
$0.7924
Intervallo di 1 settimana:
$0.58
$0.7924
Portata 52W:
$0.495
$4.98
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Nome
Collplant Biotechnologies Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare CLGN vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
0.7502 | 9.10M | 2.48M | -12.16M | -10.35M | -1.0219 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-02-17 | Iniziato | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Borsa (CLGN) Ultime notizie
CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Profit Outlook - simplywall.st
CollPlant Biotechnologies Faces Nasdaq Bid-Price Deficiency, Granted Compliance Window - TipRanks
CollPlant (CLGN) receives Nasdaq minimum bid-price notice, given time to cure - Stock Titan
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement - PR Newswire
CollPlant Biotechnologies (CLGN) CEO Tal Yehiel details option and RSU holdings - Stock Titan
CollPlant (CLGN) director Alisa Lask details option and RSU holdings - Stock Titan
CollPlant Biotechnologies (CLGN) director reports options and RSUs on Form 3 - Stock Titan
CollPlant Biotechnologies (CLGN) director details option and RSU stake - Stock Titan
CollPlant (CLGN) VP reports 25,000 RSUs with 4-year vesting - Stock Titan
CollPlant (NASDAQ: CLGN) VP Legal details options and RSU awards - Stock Titan
CollPlant (CLGN) VP details option and restricted share unit holdings - Stock Titan
CollPlant (NASDAQ: CLGN) VP discloses options, RSUs and shares in Form 3 - Stock Titan
CollPlant (CLGN) VP details options and RSUs stake - Stock Titan
CollPlant Biotechnologies (NASDAQ: CLGN) deputy CEO details option and RSU stakes - Stock Titan
CollPlant Biotechnologies Launches Redesigned Corporate Website - Finviz
CollPlant Biotechnologies Launches Redesigned Corporate Website - Benzinga
Reviewing CG Oncology (NASDAQ:CGON) and CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS - Finviz
Biotech CollPlant to unveil 2025 results before U.S. market open - Stock Titan
CLGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler - Intellectia AI
CollPlant secures Korean patent for dermal filler technology - Investing.com Australia
Collplant Biotechnologies Announces Korean Patent Allowance Secured for Its Photocurable Dermal Filler - marketscreener.com
CollPlant (CLGN) Receives Korean Patent for Dermal Filler Techno - GuruFocus
CollPlant Secures Korean Patent Allowance for Photocurable Dermal Filler Platform - TipRanks
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler - Revista ADVFN
CollPlant launches BioFlex bioink kit for 3D bioprinting By Investing.com - Investing.com India
CollPlant Launches BioFlex rhCollagen Bioink Kit to Advance 3D Bioprinting - The Globe and Mail
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference - Intellectia AI
BioFlex launch expands CollPlant (NASDAQ: CLGN) 3D bioprinting portfolio - Stock Titan
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex - Barchart.com
What’s the outlook for CollPlant Biotechnologies Ltd.’s sectorRate Hike & High Win Rate Trade Alerts - mfd.ru
CollPlant Moves to Capture GLP-1-Driven Aesthetic Market With Photocurable rhCollagen Filler - TipRanks
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments - marketscreener.com
New rhCollagen filler targets faces thinned by GLP-1 weight loss - Stock Titan
What is CollPlant Biotechnologies Ltd. s debt to equity ratioJuly 2025 Sentiment & Weekly High Conviction Ideas - mfd.ru
A | Does CollPlant Biotechnologies Ltd. stock have upside surprise potential - mfd.ru
Will CollPlant Biotechnologies Ltd. stock rally after Fed decisionsJuly 2025 Review & Daily Stock Momentum Reports - mfd.ru
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Turn A Profit? - Yahoo Finance
CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital - Investing.com Australia
CollPlant Biotechnologies Raises $2 Million in Registered Direct Offering with Concurrent Warrant Placement - TipRanks
This Impinj Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday - Benzinga
CollPlant (CLGN) to raise about $2.0M via direct share sale and warrants - Stock Titan
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering - Yahoo Finance
United States shares lower at close of trade; Dow Jones Industrial Average down 1.20% By Investing.com - Investing.com India
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.20% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.20% - Investing.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
CollPlant (CLGN) Announces Stock Offering and Private Placement - GuruFocus
CollPlant raises $2M, sells 1.6M shares and issues warrants - Stock Titan
Collplant Biotechnologies Ltd Azioni (CLGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):